Strides Pharma Science informs about press release

22 May 2024 Evaluate
Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

628.50 -71.05 (-10.16%)
04-Apr-2025 15:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.50
Dr. Reddys Lab 1112.00
Cipla 1416.00
Lupin 1972.00
Zydus Lifesciences 868.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...